-

Product Pipeline Analysis for TTK Healthcare Ltd (TTKHLTCARE), 2019 Update - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "TTK Healthcare Ltd (TTKHLTCARE) - Product Pipeline Analysis, 2019 Update" company profile has been added to ResearchAndMarkets.com's offering.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

TTK Healthcare Ltd (TTK Healthcare), a subsidiary of TTK Group, is a healthcare service provider that offers pharmaceuticals, consumer products and biomedical devices through its divisions. The company offers products in various areas such as personal care, baby care, pharmaceuticals, animal care, heart valve and orthopaedic implants.

It also specializes in ready-to-fry snack pellets and map-based publications. TTK Healthcare exports allopathic and herbal products, artificial heart valves, hernia repair mesh, gripe water, cosmetics, baby care products, ready to fry food pellets and maps, among others. The company provides animal care products through its animal welfare division. TTK Healthcare is headquartered in Chennai, Tamil Nadu, India.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company TTK Healthcare Ltd
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Key Topics Covered:

  • TTK Healthcare Ltd Company Overview
  • TTK Healthcare Ltd Company Snapshot
  • TTK Healthcare Ltd Pipeline Products and Ongoing Clinical Trials Overview
  • TTK Healthcare Ltd - Pipeline Analysis Overview
  • TTK Healthcare Ltd - Key Facts
  • TTK Healthcare Ltd - Major Products and Services
  • TTK Healthcare Ltd Pipeline Products by Development Stage
  • TTK Healthcare Ltd Pipeline Products Overview
  • Chitra Vascular Graft
  • Chitra Vascular Graft Product Overview
  • Mitral Annuloplasty Ring
  • Mitral Annuloplasty Ring Product Overview
  • Second Generation TTK-Chitra Heart valve
  • Second Generation TTK-Chitra Heart valve Product Overview
  • TTK Healthcare Ltd - Key Competitors
  • TTK Healthcare Ltd - Key Employees
  • TTK Healthcare Ltd - Locations And Subsidiaries
  • Head Office
  • Recent Developments
  • TTK Healthcare Ltd, Recent Developments
  • May 30, 2017: Ttk Healthcare Reports Total Income Of INR5.3 Billion In Fiscal 2017
  • May 27, 2013: TTK Healthcare Reports Revenue Of INR3.8 Billion In Fiscal 2013
  • Feb 01, 2013: TTK Healthcare Reports Revenue Of INR921.8m In Q3 Fiscal 2013
  • Oct 29, 2012: TTK Healthcare Reports Revenue Of INR954.3m In Q2 Fiscal 2013
  • Aug 13, 2012: TTK Healthcare Reports Revenue Of INR1.1 Billion In Q1 Fiscal 2013
  • May 22, 2012: TTK Healthcare Reports Revenue Of INR878.1m In Q4 Fiscal 2012
  • Feb 02, 2012: TTK Healthcare Reports Revenue Of INR866.9m In Q3 Fiscal 2012
  • Nov 07, 2011: TTK Healthcare Reports Revenue Of INR864m In Q2 Fiscal 2012
  • Jul 27, 2011: TTK Healthcare Reports Revenue Of INR924.6m In Q1 Fiscal 2012
  • May 24, 2011: TTK Healthcare Reports Revenue Of INR763.3m In Q4 Fiscal 2011
  • Appendix
  • Methodology
  • About the Author
  • Contact Us
  • Disclaimer

For more information about this company profile visit https://www.researchandmarkets.com/r/ypoure

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

1 Day Clinical Trial Agreements Training Course: Key Legal, Regulatory and IP (Intellectual Property) Considerations for the EU (European Union) and UK Markets (Mar 18, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Clinical Trial Agreements: Key Legal, Regulatory and IP (Intellectual Property) Considerations for the EU (European Union) and UK Markets Training Course (Mar 18, 2026)" training has been added to ResearchAndMarkets.com's offering. The life sciences sector is heavily regulated and CTAs are some of the most important agreements for companies operating in this sector. Having appropriate CTAs in place is therefore essential for managing relationships between the diffe...

Navigating EU (European Union) and FDA (Food and Drug Administration) Regulations for Drug/Device and Device/Drug Combination Products Training Course (Mar 2nd - Mar 3rd, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Navigating EU (European Union) and FDA (Food and Drug Administration) Regulations for Drug/Device and Device/Drug Combination Products Training Course (Mar 2nd - Mar 3rd, 2026)" training has been added to ResearchAndMarkets.com's offering. Understand the regulatory frameworks governing drug/device and device/drug combinations in the European Union and the USA. The demarcation between medicinal products and devices is becoming ever more important and, with the conve...

Wedding Rings Market Trends, Shares and Growth Prospects 2025-2030 - Cultural and Social Trends Around Minimalism and Modern Design Drive Adoption of Non-Traditional Styles - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Wedding Rings - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global market for Wedding Rings was valued at US$56.7 Billion in 2024 and is projected to reach US$80.7 Billion by 2030, growing at a CAGR of 6.1% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The wedding ring market is expanding due to a combin...
Back to Newsroom